|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Consolidated Excluding VIEs | ||||||||||||||||||||
| Consolidated VIEs | ||||||||||||||||||||
| Total cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Consolidated Excluding VIEs | ||||||||||||||||||||
| Consolidated VIEs | ||||||||||||||||||||
| Total restricted cash | ||||||||||||||||||||
| Loans, net (including $388 and $737 held at fair value) | ||||||||||||||||||||
| Consolidated Excluding VIEs | ||||||||||||||||||||
| Total loans, net (including $388 and $737 held at fair value) | ||||||||||||||||||||
| Loans, held-for-sale, at fair value | ||||||||||||||||||||
| Paycheck Protection Program loans (including $165 and $576 held at fair value) | ||||||||||||||||||||
| Loans, held for sale (including $89,380 and $81,599 held at fair value and net of valuation allowance of $217,719 and $0) | ||||||||||||||||||||
| Consolidated Excluding VIEs | ||||||||||||||||||||
| Total loans, held for sale (including $89,380 and $81,599 held at fair value and net of valuation allowance of $217,719 and $0) | ||||||||||||||||||||
| Loans, held for sale (including $61,314 and $73,094 held at fair value and net of valuation allowance of $70,867 and $67,612) | ||||||||||||||||||||
| Consolidated Excluding VIEs | ||||||||||||||||||||
| Consolidated VIEs | ||||||||||||||||||||
| Total loans, held for sale (including $61,314 and $73,094 held at fair value and net of valuation allowance of $70,867 and $67,612) | ||||||||||||||||||||
| Mortgage-backed securities | ||||||||||||||||||||
| Loans eligible for repurchase from Ginnie Mae | ||||||||||||||||||||
| Investment in unconsolidated joint ventures (including $5,294 and $5,737 held at fair value) | ||||||||||||||||||||
| Purchased future receivables, net | ||||||||||||||||||||
| Derivative instruments | ||||||||||||||||||||
| Servicing rights | ||||||||||||||||||||
| Real estate owned | ||||||||||||||||||||
| Consolidated VIEs | ||||||||||||||||||||
| Total real estate owned | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Consolidated Excluding VIEs | ||||||||||||||||||||
| Total other assets | ||||||||||||||||||||
| Assets of consolidated VIEs | ||||||||||||||||||||
| Consolidated VIEs | ||||||||||||||||||||
| Total assets of consolidated VIEs | ||||||||||||||||||||
| Assets held for sale (refer to Note 9) | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Secured borrowings and Securitized debt obligations of consolidated VIEs, net | ||||||||||||||||||||
| Consolidated Excluding VIEs | ||||||||||||||||||||
| Consolidated VIEs | ||||||||||||||||||||
| Total secured borrowings and Securitized debt obligations of consolidated VIEs, net | ||||||||||||||||||||
| Paycheck Protection Program Liquidity Facility (PPPLF) borrowings | ||||||||||||||||||||
| Senior secured notes, net | ||||||||||||||||||||
| Corporate debt, net | ||||||||||||||||||||
| Guaranteed loan financing | ||||||||||||||||||||
| Contingent consideration | ||||||||||||||||||||
| Liabilities for loans eligible for repurchase from Ginnie Mae | ||||||||||||||||||||
| Derivative instruments | ||||||||||||||||||||
| Dividends payable | ||||||||||||||||||||
| Loan participations sold | ||||||||||||||||||||
| Due to third parties | ||||||||||||||||||||
| Consolidated Excluding VIEs | ||||||||||||||||||||
| Consolidated VIEs | ||||||||||||||||||||
| Total due to third parties | ||||||||||||||||||||
| Accounts payable and other accrued liabilities | ||||||||||||||||||||
| Consolidated Excluding VIEs | ||||||||||||||||||||
| Consolidated VIEs | ||||||||||||||||||||
| Total accounts payable and other accrued liabilities | ||||||||||||||||||||
| Liabilities held for sale (refer to Note 9) | ||||||||||||||||||||
| Consolidated VIEs | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Preferred stock Series C, liquidation preference $25.00 per share (refer to Note 20) | ||||||||||||||||||||
| Stockholders’ Equity | ||||||||||||||||||||
| Preferred stock Series E, liquidation preference $25.00 per share (refer to Note 20) | ||||||||||||||||||||
| Common stock, $0.0001 par value, 500,000,000 shares authorized, 165,209,516 and 163,010,012 shares issued and outstanding, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained deficit | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total Ready Capital Corporation equity | ||||||||||||||||||||
| Non-controlling interests | ||||||||||||||||||||
| Total Stockholders’ Equity | ||||||||||||||||||||
| Total Liabilities, Redeemable Preferred Stock, and Stockholders’ Equity | ||||||||||||||||||||
Loading...
